Investments
30Portfolio Exits
13Funds
3
Want to inform investors similar to Soleus Capital Management about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Latest Soleus Capital Management News
Dec 7, 2021
This brings the company's total financing to over $800 million since the company was founded in 2014. This round of financing was led by investors Perceptive Advisors and RA Capital Management, joined by existing investors including a16z Life Sciences Growth Fund, the American Cancer Society's BrightEdge Ventures, Artis Ventures, Bain Capital Life Sciences, Catalio Capital Management, Cormorant Capital, DCVC, Farallon Capital Management, Fidelity Management and Research Company LLC, GV, Janus Henderson Investors, Kaiser Permanente, Novartis, Polaris Partners, Ridgeback Capital Management, Roche Venture Fund, Rock Springs Capital, Sands Capital, Section 32, Soleus Capital Management, with funds and accounts advised by T. Rowe Price Associates, Inc. In addition, there were several new biotech institutional investors well-placed to support the company's mission including ArrowMark Partners, Byers Capital, Eventide Asset Management LLC, HBM Healthcare Investments, Intermountain Ventures, Logos Capital, Pura Vida Investments, Suvretta Capital Management, and other undisclosed funds. Freenome is a biotechnology company with a comprehensive multiomics platform for early cancer detection using a routine blood draw. The company combines its deep expertise in molecular biology with advanced computational biology and machine learning to detect disease-associated patterns among billions of circulating cell-free biomarkers. (c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about page.
Soleus Capital Management Investments
30 Investments
Soleus Capital Management has made 30 investments. Their latest investment was in RayzeBio as part of their Series D on September 9, 2022.
Soleus Capital Management Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
9/13/2022 | Series D | RayzeBio | $160M | Yes | Ally Bridge Group, Laurion Capital Management, Sands Capital, Sofinnova Partners, Soleus Capital Management, Undisclosed Investors, Viking Global Investors, and Wellington Management | 8 |
4/5/2022 | Series D | LimFlow | $40M | Yes | Balestier, Bpifrance, Longitude Capital, Sofinnova Partners, Soleus Capital Management, and Undisclosed Angel Investors | 2 |
2/18/2022 | Series C | Beta Bionics | $57M | No | 4 | |
2/15/2022 | Series B | |||||
11/3/2021 | Series B - II |
Date | 9/13/2022 | 4/5/2022 | 2/18/2022 | 2/15/2022 | 11/3/2021 |
|---|---|---|---|---|---|
Round | Series D | Series D | Series C | Series B | Series B - II |
Company | RayzeBio | LimFlow | Beta Bionics | ||
Amount | $160M | $40M | $57M | ||
New? | Yes | Yes | No | ||
Co-Investors | Ally Bridge Group, Laurion Capital Management, Sands Capital, Sofinnova Partners, Soleus Capital Management, Undisclosed Investors, Viking Global Investors, and Wellington Management | Balestier, Bpifrance, Longitude Capital, Sofinnova Partners, Soleus Capital Management, and Undisclosed Angel Investors | |||
Sources | 8 | 2 | 4 |
Soleus Capital Management Portfolio Exits
13 Portfolio Exits
Soleus Capital Management has 13 portfolio exits. Their latest portfolio exit was Orchestra BioMed on January 26, 2023.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
1/26/2023 | Reverse Merger | 3 | |||
9/8/2022 | Asset Sale | 2 | |||
11/5/2021 | IPO | Public | 12 | ||
Date | 1/26/2023 | 9/8/2022 | 11/5/2021 | ||
|---|---|---|---|---|---|
Exit | Reverse Merger | Asset Sale | IPO | ||
Companies | |||||
Valuation | |||||
Acquirer | Public | ||||
Sources | 3 | 2 | 12 |
Soleus Capital Management Fund History
3 Fund Histories
Soleus Capital Management has 3 funds, including Soleus BA SPV.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
12/3/2020 | Soleus BA SPV | $5.65M | 1 | ||
10/7/2020 | Soleus Private Equity Fund I | ||||
5/29/2019 | Soleus BB SPV |
Closing Date | 12/3/2020 | 10/7/2020 | 5/29/2019 |
|---|---|---|---|
Fund | Soleus BA SPV | Soleus Private Equity Fund I | Soleus BB SPV |
Fund Type | |||
Status | |||
Amount | $5.65M | ||
Sources | 1 |
Soleus Capital Management Team
1 Team Member
Soleus Capital Management has 1 team member, including current Chief Operating Officer, Steven J Musumeci.
Name | Work History | Title | Status |
|---|---|---|---|
Steven J Musumeci | Chief Operating Officer | Current |
Name | Steven J Musumeci |
|---|---|
Work History | |
Title | Chief Operating Officer |
Status | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.